These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 31623163)

  • 21. Role of Epithelial-to-Mesenchymal Transition for the Generation of Circulating Tumors Cells and Cancer Cell Dissemination.
    Noubissi Nzeteu GA; Geismann C; Arlt A; Hoogwater FJH; Nijkamp MW; Meyer NH; Bockhorn M
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NK cells-directed therapies target circulating tumor cells and metastasis.
    Dianat-Moghadam H; Mahari A; Heidarifard M; Parnianfard N; Pourmousavi-Kh L; Rahbarghazi R; Amoozgar Z
    Cancer Lett; 2021 Jan; 497():41-53. PubMed ID: 32987138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model for the dissemination of circulating tumour cell clusters involving platelet recruitment and a plastic switch between cooperative and individual behaviours.
    Hapeman JD; Carneiro CS; Nedelcu AM
    BMC Ecol Evol; 2023 Aug; 23(1):39. PubMed ID: 37605189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of CTC Clusters in Breast Cancer Metastasis.
    Piñeiro R; Martínez-Pena I; López-López R
    Adv Exp Med Biol; 2020; 1220():93-115. PubMed ID: 32304082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?
    Fridrichova I; Kalinkova L; Ciernikova S
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?
    Ward MP; E Kane L; A Norris L; Mohamed BM; Kelly T; Bates M; Clarke A; Brady N; Martin CM; Brooks RD; Brooks DA; Selemidis S; Hanniffy S; Dixon EP; A O'Toole S; J O'Leary J
    Mol Cancer; 2021 Mar; 20(1):59. PubMed ID: 33789677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
    Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
    Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modelling metastasis in zebrafish unveils regulatory interactions of cancer-associated fibroblasts with circulating tumour cells.
    Hurtado P; Martínez-Pena I; Yepes-Rodríguez S; Bascoy-Otero M; Abuín C; Fernández-Santiago C; Sánchez L; López-López R; Piñeiro R
    Front Cell Dev Biol; 2023; 11():1076432. PubMed ID: 36949770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells.
    Micalizzi DS; Haber DA; Maheswaran S
    Mol Oncol; 2017 Jul; 11(7):770-780. PubMed ID: 28544498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metastatic niche formation: focus on extracellular vesicle-mediated dialogue between lung cancer cells and the microenvironment.
    Pontis F; Roz L; Fortunato O; Bertolini G
    Front Oncol; 2023; 13():1116783. PubMed ID: 37207158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating extracellular vesicles and tumor cells: sticky partners in metastasis.
    Jerabkova-Roda K; Dupas A; Osmani N; Hyenne V; Goetz JG
    Trends Cancer; 2022 Oct; 8(10):799-805. PubMed ID: 35644773
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Eslami-S Z; Cortés-Hernández LE; Glogovitis I; Antunes-Ferreira M; D'Ambrosi S; Kurma K; Garima F; Cayrefourcq L; Best MG; Koppers-Lalic D; Wurdinger T; Alix-Panabières C
    Front Cell Dev Biol; 2023; 11():1209846. PubMed ID: 37601099
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity.
    McInnes LM; Jacobson N; Redfern A; Dowling A; Thompson EW; Saunders CM
    Front Oncol; 2015; 5():42. PubMed ID: 25767772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor cells from melanoma patients show phenotypic plasticity and metastatic potential in xenograft NOD.CB17 mice.
    Felici C; Mannavola F; Stucci LS; Duda L; Cafforio P; Porta C; Tucci M
    BMC Cancer; 2022 Jul; 22(1):754. PubMed ID: 35820816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer-associated fibroblasts: Key criminals of tumor pre-metastatic niche.
    Dong G; Chen P; Xu Y; Liu T; Yin R
    Cancer Lett; 2023 Jul; 566():216234. PubMed ID: 37236390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and biological significance of circulating tumor cells in cancer.
    Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
    Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1.
    Hu B; Tian X; Li Y; Liu Y; Yang T; Han Z; An J; Kong L; Li Y
    Cancer Med; 2020 Apr; 9(8):2686-2697. PubMed ID: 32077634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Biophysical Model Uncovers the Size Distribution of Migrating Cell Clusters across Cancer Types.
    Bocci F; Kumar Jolly M; Onuchic JN
    Cancer Res; 2019 Nov; 79(21):5527-5535. PubMed ID: 31481500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study.
    Massard C; Oulhen M; Le Moulec S; Auger N; Foulon S; Abou-Lovergne A; Billiot F; Valent A; Marty V; Loriot Y; Fizazi K; Vielh P; Farace F
    Oncotarget; 2016 Aug; 7(34):55069-55082. PubMed ID: 27391263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.